A detailed history of Cibc Private Wealth Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,308 shares of NVAX stock, worth $20,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,308
Previous 2,308 -0.0%
Holding current value
$20,195
Previous $29,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$3.89 - $20.97 $7,780 - $41,940
2,000 Added 649.35%
2,308 $29,000
Q1 2024

May 10, 2024

BUY
$3.76 - $6.02 $1,158 - $1,854
308 New
308 $1,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $684M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.